Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.34M Sell
61,087
-2,412
-4% -$218K ﹤0.01% 1961
2014
Q2
$5.58M Sell
63,499
-10,022
-14% -$868K ﹤0.01% 1854
2014
Q1
$6.2M Buy
73,521
+4,276
+6% +$341K 0.01% 1655
2013
Q4
$5.44M Buy
69,245
+2,114
+3% +$180K 0.01% 1790
2013
Q3
$5.72M Buy
67,131
+8,415
+14% +$709K 0.01% 1598
2013
Q2
$5.05M Buy
+58,716
New +$4.87M 0.01% 1604

Other funds holding LH

UBS's LH Position: Q3 2014 in Review

UBS reduced its Labcorp (LH) stake by 3.8% in Q3 2014, selling an estimated $218K and leaving 61,087 shares worth $5.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

UBS first reported a position in LH in Q2 2013 and has held it in 6 quarters since. The position peaked at $6.2M in Q1 2014. 525 funds tracked by Wall St. Rank hold LH as of Q3 2014.

  • UBS held 61,087 shares of Labcorp worth $5.34M as of Q3 2014.
  • UBS sold 2,412 Labcorp shares in Q3 2014, an estimated $218K.
  • Labcorp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #1961 holding.
  • UBS first reported a position in Labcorp in Q2 2013 and has held it in 6 quarters since.
  • UBS's Labcorp position peaked at $6.2M in Q1 2014.
  • 525 funds tracked by Wall St. Rank held Labcorp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.